S. 127 · 118th Congress

Pharmacy Benefit Manager Transparency Act of 2023

Introduced on Jan 26, 2023 by Maria Cantwell (D-WA). 14 cosponsors, 10 of them from another party. Latest action (Dec 13, 2023): Placed on Senate Legislative Calendar under General Orders. Calendar No. 283.

Stage
Reported by committee
Introduced
Jan 26, 2023
Cosponsors
14
10 from the other party
Policy area
Health
Open in the Congress explorerCongress.govAlert me

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.

Subjects

  • Civil actions and liability
  • Congressional oversight
  • Government information and archives
  • Government studies and investigations
  • Health care costs and insurance
  • Medical ethics
  • Prescription drugs
  • State and local government operations

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Maria CantwellD-WASponsor

Democrats · 4

Republicans · 10

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jan 26, 2023Introduced in Senate
  2. Jan 26, 2023 · SenateRead twice and referred to the Committee on Commerce, Science, and Transportation.
  3. Mar 22, 2023 · SenateCommittee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Dec 13, 2023Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
  5. Dec 13, 2023 · SenateCommittee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
  6. Dec 13, 2023 · SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 283.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA18 reports
    $37.4M reported (all issues)
  2. BRISTOL-MYERS SQUIBB COMPANY10 reports
    $6.2M reported (all issues)Federal contractor: BRISTOL-MYERS SQUIBB COMPANY$8.8M in contracts, FY2026AI match · 100%
  3. THE KROGER CO.10 reports
    $4.2M reported (all issues)
  4. CENTER FOR FREEDOM AND PROSPERITY9 reports
  5. INDEPENDENT PHARMACY COOPERATIVE9 reports
    $240K reported (all issues)Federal contractor: INDEPENDENT PHARMACY COOPERATIVEAI match · 99%
  6. TAKEDA PHARMACEUTICALS AMERICA, INC.9 reports
    $3M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  7. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION8 reports
    $17.8M reported (all issues)
  8. Pharmaceutical Care Management Association (PCMA)8 reports
    $510K reported (all issues)
  9. AMGEN INC.7 reports
    $15.2M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  10. Blue Cross and Blue Shield of Florida, Inc.6 reports
    $1.1M reported (all issues)
  11. ELEVANCE HEALTH, INC.6 reports
    $7.6M reported (all issues)
  12. GENENTECH INC.6 reports
    Federal contractor: GENENTECH USA, INC$939.6K in contracts, FY2026AI match · 100%
  13. GUIDEWELL MUTUAL HOLDING CORPORATION6 reports
    $30K reported (all issues)
  14. TEVA PHARMACEUTICALS USA, INC.6 reports
    $2.5M reported (all issues)Federal contractor: TEVA PHARMACEUTICALS USA, INC.$25.9M in contracts, FY2026AI match · 100%
  15. AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)5 reports
    $14.2M reported (all issues)
  16. AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION5 reports
    $3.3M reported (all issues)
  17. AMERICAN COLLEGE OF RHEUMATOLOGY5 reports
    $460K reported (all issues)
  18. ARTHRITIS FOUNDATION5 reports
    $375K reported (all issues)
  19. ASSOCIATION FOR CLINICAL ONCOLOGY5 reports
    $1.1M reported (all issues)
  20. American Medical Association5 reports
    $30.1M reported (all issues)Federal contractor: AMERICAN MEDICAL ASSOCIATION$371K in contracts, FY2026AI match · 99%
  21. Amgen USA, Inc.5 reports
    $300K reported (all issues)Federal contractor: AMGEN USA INC$126M in contracts, FY2026AI match · 100%
  22. BCBSM, Inc.5 reports
    $150.5K reported (all issues)
  23. BIOTECHNOLOGY INNOVATION ORGANIZATION5 reports
    $8.9M reported (all issues)
  24. Blue Cross and Blue Shield Association5 reports
    $8.8M reported (all issues)
  25. CAMBIA HEALTH SOLUTIONS INC.5 reports
    $3.2M reported (all issues)
  26. CHRONIC CARE POLICY ALLIANCE5 reports
    $520K reported (all issues)
  27. CROHN'S & COLITIS FOUNDATION5 reports
    $240K reported (all issues)
  28. Chamber of Commerce of the U.S.A.5 reports
    $93.5M reported (all issues)
  29. Community Oncology Alliance5 reports
    $1.4M reported (all issues)
  30. GSK (fka GLAXOSMITHKLINE INC.)5 reports
    $6.3M reported (all issues)
  31. HIGHMARK INC.5 reports
    $830K reported (all issues)
  32. Job Creators Network5 reports
    $60K reported (all issues)
  33. KAISER FOUNDATION HEALTH PLAN INC.5 reports
    $2.9M reported (all issues)Federal contractor: KAISER FOUNDATION HEALTH PLAN OF WASHINGTONAI match · 97%
  34. LOCKHEED MARTIN CORPORATION5 reports
    $16.1M reported (all issues)Federal contractor: LOCKHEED MARTIN CORPORATION$13.3B in contracts, FY2026AI match · 100%
  35. MERCK & CO., INC.5 reports
    Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
  36. MOLINA HEALTHCARE INC5 reports
    $1.8M reported (all issues)
  37. MUTUAL OF OMAHA5 reports
    $490K reported (all issues)
  38. McKesson Corporation & affiliates U.S. Oncology and Rx Savings Solutions5 reports
    $4.2M reported (all issues)
  39. NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INC.5 reports
    $4.2M reported (all issues)
  40. NATIONAL ASSOCIATION OF MANUFACTURERS5 reports
    $12.7M reported (all issues)

Reports filed in 2023, 2024, 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.